English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Alzheimer's Association
Patient Daily Report
| Jul 18, 2023
BioArctic CEO: FDA approval of Leqembi 'is a paradigm-shifting step in the fight against Alzheimer's disease'
Trending
+
Pharmaceuticals
Patient Daily reports
| Feb 11, 2025
Health Analysts: DOGE should 'look no further than the 340b drug discount program' for savings
+
Regulatory
Patient Daily
| Feb 14, 2025
Spokesperson for Patients Come First: 340B program is ‘one of the most blatant abuses of a governmental program’
+
Pharmaceuticals
Patient Daily
| Feb 18, 2025
Understanding fainting: A look at potential cardiac implications
